These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6341732)

  • 21. [Kinetics of N-dealkylation of amines with participation of microsomal cytochrome P-450].
    Akhrem AA; Bel'skiĭ SM; Metelitsa DI
    Biokhimiia; 1978 Jan; 43(1):23-7. PubMed ID: 23870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro characterization of the cytochrome P450 isoenzymes involved in the back oxidation and N-dealkylation of reduced haloperidol.
    Pan LP; De Vriendt C; Belpaire FM
    Pharmacogenetics; 1998 Oct; 8(5):383-9. PubMed ID: 9825830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-enzymatic reduction of aliphatic tertiary amine N-oxides mediated by the haem moiety of cytochrome P450.
    Takekawa K; Kitamura S; Sugihara K; Ohta S
    Xenobiotica; 2001 Jan; 31(1):11-23. PubMed ID: 11334263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substrates of human hepatic cytochrome P450 3A4.
    Li AP; Kaminski DL; Rasmussen A
    Toxicology; 1995 Dec; 104(1-3):1-8. PubMed ID: 8560487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of CYP3A4 and CYP2D6 in the metabolism of haloperidol.
    Fang J; Baker GB; Silverstone PH; Coutts RT
    Cell Mol Neurobiol; 1997 Apr; 17(2):227-33. PubMed ID: 9140699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic activation of aromatic amines and dialkylnitrosamines.
    Lotlikar PD
    J Cancer Res Clin Oncol; 1981; 99(1-2):125-36. PubMed ID: 7251630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High variability of nitrosamine metabolism among individuals: role of cytochromes P450 2A6 and 2E1 in the dealkylation of N-nitrosodimethylamine and N-nitrosodiethylamine in mice and humans.
    Camus AM; Geneste O; Honkakoski P; Béréziat JC; Henderson CJ; Wolf CR; Bartsch H; Lang MA
    Mol Carcinog; 1993; 7(4):268-75. PubMed ID: 8352885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the mechanism of amine oxidations by P450.
    Karki SB; Dinnocenzo JP
    Xenobiotica; 1995 Jul; 25(7):711-24. PubMed ID: 7483668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxygenation mechanism for chloroperoxidase-catalyzed N-oxidation of arylamines.
    Doerge DR; Corbett MD
    Chem Res Toxicol; 1991; 4(5):556-60. PubMed ID: 1793805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential metabolic bioactivation pathways involving cyclic tertiary amines and azaarenes.
    Castagnoli N; Rimoldi JM; Bloomquist J; Castagnoli KP
    Chem Res Toxicol; 1997 Sep; 10(9):924-40. PubMed ID: 9305573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple forms of cytochrome P450 in the microsomal monooxygenase system.
    Ullrich V; Kremers P
    Arch Toxicol; 1977 Dec; 39(1-2):41-50. PubMed ID: 579981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites.
    Sutton D; Butler AM; Nadin L; Murray M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):294-300. PubMed ID: 9223567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demethylation of tertiary amines by a reconstituted cytochrome P-450 enzyme system: kinetics of oxygen consumption and hydrogen peroxide formation.
    Ristau O; Wagnerova DM; Rein H; Ruckpaul K
    J Inorg Biochem; 1989 Oct; 37(2):111-8. PubMed ID: 2600595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation.
    Tateishi T; Krivoruk Y; Ueng YF; Wood AJ; Guengerich FP; Wood M
    Anesth Analg; 1996 Jan; 82(1):167-72. PubMed ID: 8712396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced nicotinamide adenine dinucleotide-dependent reduction of tertiary amine N-oxide by liver microsomal cytochrome P-450.
    Sugiura M; Iwasaki K; Kato R
    Biochem Pharmacol; 1977 Mar; 26(6):489-95. PubMed ID: 192244
    [No Abstract]   [Full Text] [Related]  

  • 37. Specificity of rabbit pulmonary cytochrome P-450 isozymes in the activation of several aromatic amines and aflatoxin B1.
    Robertson LG; Philpot RM; Zeiger E; Wolf CR
    Mol Pharmacol; 1981 Nov; 20(3):662-8. PubMed ID: 6799775
    [No Abstract]   [Full Text] [Related]  

  • 38. Enzymatic oxidation of xenobiotic chemicals.
    Guengerich FP
    Crit Rev Biochem Mol Biol; 1990; 25(2):97-153. PubMed ID: 2183970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of tertiary amine N-oxides by liver preparations: function of aldehyde oxidase as a major N-oxide reductase.
    Kitamura S; Tatsumi K
    Biochem Biophys Res Commun; 1984 Jun; 121(3):749-54. PubMed ID: 6743317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors affecting the relative importance of amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans.
    Strolin Benedetti M; Tipton KF; Whomsley R; Baltes E
    J Neural Transm (Vienna); 2007; 114(6):787-91. PubMed ID: 17401530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.